VRAX

1.75

7.41% -0.14

Handel nachbörslich: 1.82 0.07 +4.00%

Virax Biolabs Group Ltd (VRAX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$1.89

Offen:

$1.79

24-Stunden-Volumen:

379.43K

Relative Volume:

0.22

Marktkapitalisierung:

$7.60M

Einnahmen:

$79,300

Nettoeinkommen (Verlust:

$-6.92M

KGV:

-2.7421

EPS:

-0.6382

Netto-Cashflow:

$-5.34M

1W Leistung:

+11.46%

1M Leistung:

-6.91%

6M Leistung:

+1.74%

1J Leistung:

+6.71%

1-Tages-Spanne:

$1.70

$1.9287

1-Wochen-Bereich:

$1.5143

$2.38

52-Wochen-Spanne:

$0.60

$8.9999

Virax Biolabs Group Ltd Stock (VRAX) Company Profile

Firmenname

Virax Biolabs Group Ltd

Sektor

Healthcare (1176)

Branche

Biotechnology (673)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VRAX's Discussions on Twitter

Vergleichen Sie VRAX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VRAX Virax Biolabs Group Ltd	1.75	7.60M	79,300	-6.92M	-5.34M	-18.98
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Virax Biolabs Group Ltd Aktie (VRAX) Neueste Nachrichten

Dec 17, 2024

Virax Biolabs Announces Strategic Goals and Developments for 2025 - TipRanks

Dec 17, 2024

Dec 10, 2024

Virax Biolabs Expands ImmuneSelect Reach in Europe - TipRanks

Dec 10, 2024

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland - Yahoo Finance

Dec 10, 2024

Nov 27, 2024

Virax Biolabs Group First Half 2025 Earnings: US$0.89 loss per share (vs US$1.64 loss in 1H 2024) - Simply Wall St

Nov 27, 2024

Nov 20, 2024

Virax Biolabs Sees Asset Growth Amid Financial Loss - TipRanks

Nov 20, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Virax Biolabs Group Ltd - GuruFocus.com

Nov 15, 2024

Nov 01, 2024

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - MSN

Oct 26, 2024

Oct 23, 2024

Virax Biolabs announces distribution agreement with Europa Biosite - TipRanks

Oct 23, 2024

Virax Biolabs Expands Reach with Europa Biosite Deal - TipRanks

Oct 23, 2024

EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland - Yahoo Finance

Oct 23, 2024

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland - Yahoo Finance

Oct 23, 2024

Oct 04, 2024

Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews

Oct 04, 2024

Oct 03, 2024

Analyzing the Impact of Earnings Reports on Virax Biolabs Group Ltd Inc. (VRAX) Price Performance - The InvestChronicle

Oct 03, 2024

Daily Progress: Virax Biolabs Group Ltd (VRAX) Gain 14.20, Closing at 1.85 - The Dwinnex

Oct 03, 2024

Sep 30, 2024

Virax Biolabs Plans New Share Offering - TipRanks

Sep 30, 2024

Sep 27, 2024

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session - MSN

Sep 27, 2024

Sep 25, 2024

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 72.2% in September - Defense World

Sep 25, 2024

Charting the Course: Virax Biolabs Group Ltd’s VRAX Stock Prospects - The InvestChronicle

Sep 25, 2024

Sep 23, 2024

How did Virax Biolabs Group Ltd (VRAX) fare last session? - US Post News

Sep 23, 2024

Daily Market Movement: Virax Biolabs Group Ltd (VRAX) Sees a -3.56 Decrease, Closing at 2.44 - The Dwinnex

Sep 23, 2024

Sep 17, 2024